8 years ago

Biocomposites Receives Investment from TA Associates

  • Biocomposites, a UK-based maker of calcium compound biologics, has received an investment from TA Associates

  • Barings provided senior loans to back the transaction

  • Biocomposites focuses on developing innovative calcium compounds for surgical use, with their bone graft matrices used in orthopedic procedures to regenerate bone and manage dead space

  • The company sells directly to hospitals and through independent distributors, with the United States representing its largest market.

      • ProblemHealthcare

      "Current bone graft materials often struggle in the presence of infection, leading to complications and increased recovery time for patients."

      Solution

      "Biocomposites has developed innovative calcium compound biologics that can be used in the presence of infection to regenerate bone and manage dead space during orthopedic procedures."

      Covered on